Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 3Mesothelioma, Malignant 3Lung Neoplasms 3Head and Neck Neoplasms 3Pleural Diseases 2Pancreatic Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2Glioma 2Glioblastoma 2Gallbladder Neoplasms 2Brain Neoplasms 2Bile Duct Neoplasms 2Astrocytoma 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Recurrent Head and Neck Carcinoma 1Precancerous Conditions 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Photosensitivity Disorders 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Temozolomide 85Radiotherapy 51Bevacizumab 31Irinotecan 19Radiation 16Carmustine 15Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14O(6)-benzylguanine 11Chemotherapy, Adjuvant 11Carboplatin 9sargramostim 8Thalidomide 8Imatinib Mesylate 8Filgrastim 8Surgical Procedures, Operative 6Gene Expression Profiling 6Drug Therapy 6pembrolizumab 5aldesleukin 5Topotecan 5Radiotherapy, Intensity-Modulated 5Hydroxyurea 5Gefitinib 5Etoposide 5Sorafenib 4Immunohistochemistry 4Dasatinib 4Celecoxib 4Biopsy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gliosarcoma × Dihematoporphyrin Ether × Clear all
NCT00118222 2010-06-11

High Light and Low Light Dose PDT in Glioma

Case Comprehensive Cancer Center

Phase 3 Completed
1 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡